Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference108 articles.
1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020
2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020
3. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020
4. Coronavirus disease 2019 (COVID-19) in Italy;Livingston;JAMA,2020
5. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am J Respir Crit Care Med,2011
Cited by 791 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature;Microorganisms;2024-02-04
2. CORONAVIRUS SARS-COV-2 MODIFIES ANTITUMOR REDOX STATUS OF BLOOD AND INTERCELLULAR MATRIX IN METASTATIC COLORECTAL CANCER PATIENTS (A PILOT STUDY);Experimental Oncology;2024-02-03
3. Corrigendum to “Decomposing neighborhood disparities in bicycle crashes: A Gelbach decomposition analysis” [Transport Pol. 131 (2023) 156–172];Transport Policy;2024-02
4. Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment;Journal of Drug Delivery Science and Technology;2024-02
5. Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury;Cell Reports;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3